January University of Galway appoints director of first clinical trial institute in the country

Professor Peter Doran joins University of Galway with extensive experience in leading clinical research

University of Galway has appointed Professor Peter Doran as the new director of a clinical trials institute. This new institute will transform the University’s ability to evaluate cutting-edge clinical treatments, medical diagnostics and preventative therapies. 

University President, Professor Ciarán Ó hÓgartaigh, said: “We are delighted to welcome Professor Peter Doran to University of Galway and to the College of Medicine, Nursing and Health Sciences where he will lead the new clinical trials institute.  

“As a cornerstone of our research architecture, this institute led by Professor Doran, will give further impetus and focus to translating our research discoveries from the lab-bench to the bedside and builds on our considerable strengths in Medical Technologies and Advanced Therapies.”

Professor Peter Doran earned his BSc from Dublin City University in 1998 and his PhD from University College Dublin in 2001. He was the founding Director of the UCD Clinical Research Centre. Under his leadership the UCD CRC has developed an internationally renowned clinical research programme which supports investigators to ask clinically impactful research questions in a quality assured, scientifically excellent and patient focused environment.  

Professor Peter Doran said:  “The development of the clinical trials institute at the University of Galway will have impact locally, nationally and globally. 

“Our research programme will tackle the major health issues facing society today and into the future. By developing and growing linkages with our clinical partners in Saolta, with Community Health Organisation Area 2 and with industry we will ensure that today’s health research becomes tomorrow’s healthcare. We will leverage our current expertise and experience to ensure Galway is the national lead in clinical research.”

Professor Doran leads a significant biomarker research programme and has established a high throughput biomarker validation laboratory, which is contributing to major national and international end organ damage biomarker studies, reflecting his research interests in the molecular drivers of organ damage, biomarker discovery and translation to practice.  

In addition, he established the graduate taught programme in clinical and translational research which includes a suite of programmes designed to address the career stage specific education and training requirements of clinical research personnel.  

Professor Doran has also served as Associate Dean for Research at the UCD School of Medicine, Vice-Principal for Research at the UCD College of Health & Agricultural Science and Director of the Ireland East Hospital Group research network. 

Ends